Wearable devices have often been dismissed by healthcare professionals as a consumer tool with 'fancy' features. Take a look at how healthcare delivery is changing and its impact on the wearables space, the key players, innovative business models, etc., that will transform its future.
This sector in the UK is experiencing tremendous shifts. This research analyzes the landscape based on the developments, drivers and restraints, revenue and forecast assessment. Get insight into the emerging growth opportunities and growth environment portrayed in this analysis.
The telehealth industry covered in this research includes virtual visits, mHealth and remote patient monitoring (RPM). What is the forecast for the KSA and UAE telehealth segment until 2025? What are the profitable growth opportunities available? What are the challenges involved? Find out in this research.
Fast-moving consumer goods (FMCG) companies are shaping their growth more than ever through constant innovation and the implementation of new technologies to serve their consumers better.
This traditional sector is at the heart of powerful industry convergences. Traditional value chains are impacted by transformative Mega Trends, disruptive technologies, and new business models that will reshape them faster than expected.
Five strategic pillars will support the FMCG industry in the next five years: digitization, personalization, sustainability, deglobalization and new business models.
Digitization is amongst the most disruptive trends for traditional FMCG players. From R&D to distribution, each building block of the value chain will be deeply impacted. AI, data analytics, IoT, robotics, machine learning, RPA and additive manufacturing are advanced technologies that will reshape FMCG research departments, factories, warehouses and stores while enhancing customer experience and engagement. These technologies will optimize internal processes and automate redundant and low value-added tasks. They will strengthen client intimacy by leveraging data to provide perfect custom solutions to billions of clients.
Schedule a consultation with an industry expert at no charge by contacting us at myfrost@frost.com. We are taking unprecedented action to make our team available to help you cut through the media and politics to get factual one-to-one guidance for the issues and opportunities that matter most to your business.
Access to New Therapy Areas Drives Growth in the Global Biosimilars Sector
Read more Request InfoGrowth in the Global Hemodynamic Monitoring Systems Industry
Read more Request InfoGrowth Prospects in Contract Cell and Gene Therapy Manufacturing
Read more Request InfoInnovations Driving Growth in the Mental Health Care Sector
Read more Request InfoLow-cost Devices with Simple Designs Growing in Response to COVID-19
Read more Request InfoGrowth of the Global Infectious Disease Point-of-care Testing Sector
Read more Request InfoGrowth of Computer-Assisted Coding Sector in Select EU Nations
Read more Request InfoWhat is the current and predicted
impact of COVID-19 on the growth of virtual
critical care solutions in the United States
and EU-5 countries? Which platforms are
expected to see faster adoption? How will the
new competitive dynamics impact the ecosystem
in the next five years?
Request Info
What are the recent developments
within the clinical chemistry and immunoassay
industry? What major commercial activities are
shaping the IVD landscape? What are the
high-potential short- and long-term
opportunities to achieve growth?
Request Info
Why are the strategic imperative 8â„¢
impacting the growth of immuno-oncology (I-O)
therapies? What are the characteristics of I-O
therapies? How is the clinical trials snapshot
for I-O therapies shaping up? What are the key
growth opportunities in this space?
Request Info
What will be the revenue potential of
the US and EU LIMS market from 2020 to 2026?
What are the adoption trends and market growth
curves of various products in the LIMS
industry? What are the major growth
opportunities in this industry?
Request Info
Frost & Sullivan’s recent analysis, Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026, finds that the cost-benefit for end-users (patients) and ease of partnering with specialty contract development and manufacturing organizations (CDMOs) are driving the global biosimilars market. The third wave of biosimilars, with patent expiries from 2020 onward, is expected to hit the global market, covering complex biologic molecules like certain high-value mAbs and targeted therapies. The global biosimilars market is set to grow from $30.4 billion in 2020 to $79.2 billion by 2026 at a CAGR of 17.3%.
Based on its recent analysis of the North American telehealth market, Frost & Sullivan recognizes VeeMed, Inc. with the 2020 North American Entrepreneurial Company of the Year Award. Leveraging intelligent technologies, the company provides an integrated patient-side solution that positions telephysicians to diagnose, treat, and monitor acute care patients. The company partners with well-established healthcare providers and technology companies to address market gaps and disrupt the status quo by delivering customized hardware and device-agnostic software.
The year 2020 has been game-changing. The pandemic and other geopolitical events left many businesses in an unprecedented state of uncertainty. Healthcare companies across the care continuum were faced with new challenges, and their extent and longevity are still unknown. Healthcare delivery has transformed, and the concept of “anytime anywhere care†will go mainstream. Vendors will need to redefine their visions and realign their strategies to ensure they are ready for 2021 and beyond.
Read more